Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341.

作者信息

Lee Carolyn, Waldman Todd

机构信息

Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.

出版信息

Cancer Biol Ther. 2003 Nov-Dec;2(6):700-1.

PMID:14688480

Abstract

摘要

相似文献

Human somatic cell knockouts reveal determinants of sensitivity and resistance to proteasome inhibitor PS-341.

Cancer Biol Ther. 2003 Nov-Dec;2(6):700-1.

Differential apoptotic response to the proteasome inhibitor Bortezomib [VELCADE, PS-341] in Bax-deficient and p21-deficient colon cancer cells.

Cancer Biol Ther. 2003 Nov-Dec;2(6):694-9.

Protease inhibitor-induced apoptosis: accumulation of wt p53, p21WAF1/CIP1, and induction of apoptosis are independent markers of proteasome inhibition.

Leukemia. 2000 Jul;14(7):1276-83. doi: 10.1038/sj.leu.2401812.

Promoting proteasomes: trash to treasure.

Drug Discov Today. 2003 Oct 1;8(19):866-8. doi: 10.1016/s1359-6446(03)02860-5.

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis.

Mol Cancer Ther. 2002 Aug;1(10):841-9.

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

Clin Cancer Res. 2003 Mar;9(3):1145-54.

Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.

Clin Cancer Res. 2004 Jun 1;10(11):3839-52. doi: 10.1158/1078-0432.CCR-03-0561.

Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic response to Bortezomib, a novel proteasome inhibitor, in human H460 non-small cell lung cancer cells.

J Biol Chem. 2003 Sep 5;278(36):33714-23. doi: 10.1074/jbc.M302559200. Epub 2003 Jun 23.

Molecular sequelae of proteasome inhibition in human multiple myeloma cells.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14374-9. doi: 10.1073/pnas.202445099. Epub 2002 Oct 21.

Proteasome inhibition: a novel approach to cancer therapy.

Trends Mol Med. 2002;8(4 Suppl):S49-54. doi: 10.1016/s1471-4914(02)02315-8.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验